International developed-market equities have drawn renewed attention as investors seek value-oriented and income-generating alternatives to richly valued U.S. large-cap growth stocks. Within this landscape, EFV and SCHY are frequently compared because both offer ex-U.S. developed-market exposure with a non-growth bias, yet they arrive there through structurally different methodologies. EFV is a broad, capitalization-weighted value fund, while SCHY is a targeted dividend-quality strategy. This ETF comparison matters because the two funds do not compete head-to-head on a single factor; rather, they represent alternative routes to similar investor goals of diversification, income, and relative value outside the United States. I also checked this using Tickeron’s AI Screener to see how the funds line up on key metrics.
EFV seeks to track the MSCI EAFE Value Index, a subset of the broader MSCI EAFE Index that isolates securities from Europe, Australasia, and the Far East exhibiting value characteristics. It is a passive, market-capitalization-weighted fund holding roughly 420 large-cap stocks, with approximately 91% of assets in companies above $10 billion in market capitalization. The fund has a pronounced financials tilt, with financial services representing close to 40% of the portfolio, followed by industrials, consumer staples, health care, energy, and materials. Top holdings include HSBC Holdings, Shell, Nestlé, Mitsubishi UFJ Financial Group, Roche, Allianz, Novartis, Toyota, and TotalEnergies. EFV carries a net expense ratio of approximately 0.31% and has offered a dividend yield in the mid-single-digit range, reflecting its deeper-value positioning and cyclical exposure.
SCHY tracks the Dow Jones International Dividend 100 Index, which selects roughly 100 high-dividend-yielding companies outside the United States using additional fundamental and low-volatility screens. Launched in 2021, it is a passive, rules-based strategy with approximately 100 holdings and a modified market-cap weighting scheme. Its sector allocation is notably more balanced than EFV's, with financials, consumer staples, communication services, and industrials each representing roughly 13–16% of the portfolio. Leading positions include Roche, Unilever, British American Tobacco, GSK, Wesfarmers, BHP Group, TotalEnergies, Enel, and Eni. SCHY charges a net expense ratio of about 0.08% and typically yields in the low-to-mid single digits, prioritizing dividend reliability and quality alongside yield rather than maximum income alone.
Both funds operate within the broader international developed-market equity complex, where several macro forces are shaping relative positioning. Elevated global interest rates have historically favored value and dividend-paying equities over long-duration growth, while a stronger U.S. dollar can pressure unhedged foreign returns. European banks and energy producers, prominent in both portfolios, remain sensitive to rate expectations and commodity prices, respectively. Meanwhile, capital flows have rotated periodically toward international value as investors reassess concentration risk in U.S. mega-cap technology. Regulatory and geopolitical developments across Europe and the United Kingdom also influence earnings for the financials and staples names that dominate these two funds. The key structural risk shared by both is limited technology exposure, which reduces correlation to growth-led rallies but can weigh on relative performance when momentum favors high-growth sectors.
In recent weeks and months, both funds have benefited from a broader rotation toward international value and dividend-oriented equities, though their relative positioning has diverged in important ways. EFV's heavy financials allocation has made it more sensitive to shifts in global rate expectations and bank earnings cycles, contributing to comparatively higher volatility. SCHY, with its quality and low-volatility screens, has generally exhibited a lower beta and more defensive sector profile, supported by staples, health care, and communication services. On an income basis, EFV has tended to offer a higher yield, while SCHY has emphasized steadier, quality-screened dividends. For relative positioning, investors favoring cyclical value exposure and higher income have leaned toward EFV, while those prioritizing lower costs, diversification, and reduced drawdown risk have gravitated toward SCHY.
Based on observable structural factors, Tickeron's AI would likely favor SCHY over EFV in the current environment. SCHY's materially lower expense ratio, more balanced sector diversification, quality-focused selection methodology, and historically lower volatility support a more favorable risk-adjusted profile. While EFV offers deeper value exposure and a higher headline yield, its concentration in financials and its higher fee introduce incremental cyclical and cost-related risk. The probabilistic assessment favors SCHY for cost efficiency and defensive positioning, though EFV remains a reasonable choice for investors explicitly seeking broader developed-market value exposure. This is an analytical observation, not personalized investment advice. From what I see, the lower-cost, quality tilt in SCHY stands out when weighing risk-adjusted outcomes.
In my own analysis of funds like these, I often turn to Tickeron’s AI Screener to quickly compare holdings, sector exposures, and momentum signals across ETFs. It lets me apply custom filters for volatility, fundamentals, and performance metrics, which helps surface relative strengths without sifting through dozens of data points manually. The tool has become a regular part of how I evaluate international strategies before making allocation decisions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 50-day moving average for EFV moved below the 200-day moving average on November 11, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EFV as a result. In 61 of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.
The Moving Average Convergence Divergence Histogram (MACD) for EFV turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 37 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.
EFV moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EFV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
The Aroon Indicator for EFV entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +0.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where EFV advanced for three days, in 292 of 339 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
EFV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows